SCHEMBL12429200

SCHEMBL12429200

CCOC(=O)c1cn(CCCC(C)(C)[Si](C)(C)O)nc1NC(=O)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 1/20 0.40
▸ TEAD2 Q15562 1/20 0.37
▸ FOS P01100 4/20 0.34
▸ JUN P05412 4/20 0.34
▸ NFKB1 P19838 4/20 0.34
▸ NFKB2 Q00653 4/20 0.34
▸ RELA Q04206 4/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ADORA3 P0DMS8 5/20 0.33
▸ ADORA2A P29274 3/20 0.33
▸ ADORA1 P30542 3/20 0.33
▸ KDM4E B2RXH2 4/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ NPC1 O15118 3/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ HTT P42858 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12429199 0.86 TEAD2 (0.39) TEAD2FOSJUNNFKB1NFKB2
SCHEMBL15026118 0.81 TRPM8 (0.41) TRPM8TEAD2FOSJUNNFKB1
SCHEMBL12429198 0.80 TEAD2 (0.43) TEAD2NFKB1NFKB2RELAADORA3
SCHEMBL12429194 0.79 TEAD2 (0.36) TEAD2FOSJUNNFKB1NFKB2
SCHEMBL8694246 0.70 TEAD2 (0.41) TEAD2KDM4EALDH1A1HPGDMAPT
SCHEMBL8696080 0.69 TEAD2 (0.41) TEAD2CYP2C19KDM4ERAB9AHTT
SCHEMBL8693098 0.69 HTT (0.43) TEAD2KDM4ENPC1RAB9AHTT
SCHEMBL8693715 0.68 TEAD2 (0.40) TEAD2FOSJUNNFKB1NFKB2
SCHEMBL8693052 0.68 TEAD2 (0.40) TEAD2KDM4ENPC1RAB9AHPGD
SCHEMBL8692506 0.68 TEAD2 (0.39) TEAD2FOSJUNNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 — — US disclosed
WO-2011100838-A1 DERIVATIVES OF 1-PHENYL-1,5-DIHYDRO-BENZO[B] [1.4]DIAZEPINE-2.4-DIONE AS INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication MED1, ZC3HAV1, BET1 TRPM8 4460/4885TEAD2 1637/4885FOS 3262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback